Stratec Biomedical AG (EU: SBS) was downgraded by equities research analysts at HSBC from a “neutral” rating to an “underweight” rating in a research note issued to investors on Thursday.

Shares of Stratec Biomedical AG traded up 0.06% during mid-day trading on Thursday, hitting $48.16. Stratec Biomedical AG has a one year low of $33.70 and a one year high of $48.88. The stock’s 50-day moving average is currently $46.33. The company has a market cap of $5.486 billion and a P/E ratio of 6.81.

Companhia de Saneamento Basico do Estado de Sao Paulo – SABESP (SABESP) is a Brazil-based company which provides basic and environmental sanitation services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.